BNTC - Benitec Biopharma In...

Benitec Biopharma Inc.

BNTC

NASDAQ

Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.

11.58 USD

0.34 (2.94%)

Overview Profile Financial Statements Financial Ratios Chart Analysis News Corporate Actions DCF

BNTC Ratings

Upgrades & Downgrades

We are unable to load this data!

Price Targets

We are unable to load the data!

FMP

Home Terms of Service Privacy Policy Blog Careers FAQs Contact Us

API

Documentation Pricing Formulas Market Indexes

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.